ABBOTT LABORATORIES acquired IDEV Technologies, Inc. for $310M, a transaction announced in July 2013, structured as Acquisition (all outstanding equity).
IDEV Technologies, Inc. operates in Vascular / Medical Devices, is based in United States. IDEV Technologies, headquartered in Webster, Texas, is a privately held company developing next-generation devices for interventional radiologists, vascular surgeons and cardiologists, including the SUPERA Veritas self-expanding interwoven-nitinol stent for treating peripheral artery disease. Abbott acquired all outstanding equity to expand and complement its peripheral-vascular portfolio of guidewires, balloon catheters and stents.
Expands Abbott's peripheral-technology portfolio into one of the most comprehensive in the industry for treating PAD.
Advisory firms were not disclosed for this transaction.